CClinicalTrials.gg
RecruitingNCT05709470Mind the HeartUpdated Sep 26, 2025

Mind the Heart - Mental Health in Children and Adolescents With Congenital Heart Defects

An observational study in Heart Defects, Congenital and Mental Health Issue, sponsored by Rigshospitalet, Denmark. Recruiting at 1 site in Denmark. Open to participants aged 5 Years to 17 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-09-26.

Sponsored by Rigshospitalet, Denmark · Observational

From the registry’s dates

  • Primary completion was expected by Dec 2025, 9 months ago, but the record still lists the study as recruiting.
  • Started Mar 2023; still recruiting 3 years 6 months later.
Study type
Observational
Model
Case-only
Time perspective
Cross-sectional
Enrollment
4,800
Ages
5 Years to 17 Years
Sex
All
01

Study summary

The aim of the Mind the Heart study is to document the feasibility of an online parent/child administered screening model for mental disorders (MDs) in Danish children and adolescents with congenital heart disease (CHD). As MDs in children and adolescents with chronic somatic health issues are frequently underdiagnosed and undertreated, we further aim to develop a website with evidence based information on mental health in children and adolescents with CHD in order to promote knowledge and awareness among families and health professionals across sectors.

Read the detailed description

Background:

CHD affects approximately 6-10 children per 1000 live births. Innovations in somatic treatment during the last 50 years have increased survival in children with CHD, but also showed a higher risk of cognitive disabilities and MDs like depression, ADHD and autism in children and adolescents with CHD compared to the general population. Untreated childhood MDs may have serious implications for the child's social and academic functioning, quality of life, future health and employment.

Methods:

Danish children and adolescents diagnosed with CHD (N \~ 4800) will be identified through Danish national registries. Parents to eligible children and adolescents will complete bespoke online questionnaires on sociodemographic factors and received psychological support for their children.

Our initial plan was to use the SDQ and DAWBA set-up for the entire CHD group, but based on the low participation rates in the first two CHD groups (the Fontans and ASDs) the set-up was simplified.

The set-up we used is as follows:

Set-up for Fontan and Atrial Septal Defects:

Parents and children ≥ 11 years will complete the internet based Strength and Difficulties Questionnaires (SDQ) and the Development and Wellbeing Assessment (DAWBA). The DAWBA data will be rated by trained clinicians for a possible, probably or no specific psychiatric diagnosis. A summarising report of the results from the DAWBA will be provided to the families within 3 months. Parents will be asked to complete a feasibility questionnaire on the screening procedure, including if they think it would be beneficial to adopt such a procedure in typical clinical practice. The feasibility of the entire online screening procedure will be evaluated.

Set-up for other CHD sub-types:

Parents to children and adolescents will complete the internet based Strength and Difficulties Questionnaire (SDQ). Using the predictive algorithms the probabality of any psychiatric disorder is categorised as either possible, probable or unlikely. Unmet mental health needs will be evaluated.

Emotional and behavioral symptoms and unmet mental health needs will be evaluated in different CHD subtypes separately and across subtypes.

In collaboration with families and cross-sectoral health care providers, a website will be developed. User needs will be identified through semi-structured interviews with representative end users, and the written content will be developed based on a systematic review of the scientific literature, including systematic reviews and meta-analysis, that either illuminates aetiological and maintaining factors for MDs in children and adolescents with CHD, or describes and tests various interventions, and a review of existing information material and management guidelines. The website will be hosted at Rigshospitalet. End user satisfaction will be evaluated through a bespoke questionnaire combined with the System Usability Scale.

The semi-structured interviews with the parents to children and adolescents with CHD and concurrent MDs will further be used for a qualitative study to explore their lived experiences of these issues (Linking Heart and Mind, described elsewhere (https://osf.io/93nb6)).

02

Conditions studied

  • Heart Defects, Congenital
  • Mental Health Issue

Keywords

  • Heart Defects, Congenital
  • Mental Health
  • Child
  • Adolescent
  • Surveys
  • Questionnaires
  • Psychiatry
03

In context

Heart Defects, Congenital

1,007 studies on the registry are indexed under Heart Defects, Congenital; 257 are open to participants now.

This study's planned enrollment of 4,800 is above the median of 121 across 442 observational studies indexed under Heart Defects, Congenital.

Browse Heart Defects, Congenital studies →

Lead sponsor

Rigshospitalet, Denmark is the lead sponsor of 1,017 studies on the registry; 183 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
5 Years to 17 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

The population will be selected though the Danish registries by age and diagnosis of a congenital heart defect (clinical cohort).

Inclusion criteria

  • Born with a Congenital Heart Defect
  • Age 5-17y
  • (Living in Denmark)

Exclusion criteria

Exclusion Criteria:

  • Younger than 5years of age
  • Older than 17years of age
  • Lacking sufficient Danish language skills to answer the questionnaire
05

Study design

Observational model
Case-only
Time perspective
Cross-sectional
Enrollment
4,800 participants (estimated)
Patient registry
No

Groups and cohorts

  • Children and adolescents with congenital heart defects

    Children and adolescents between 5-17 years of age, born with a congenital heart defect, living in Denmark at the inclusion time. Participants are found though the Danish registries by a diagnosis of congenital heart defect. The diagnosis of Congenital Heart Defect must be given at one of the four University Hospitals in Denmark. These criteria are applied to ensure the validity of the diagnoses. Data will be analysed and grouped based on CHD subgroups and as a whole CHD group.

    Other: No-intervention

Interventions

  • OtherNo-intervention

    Observational cross-sectional study design with no intervention

06

What researchers measure

Primary outcomes

  1. Psychiatric diagnosis

    Number of participants fulfilling the ICD-10/DSM-5 criteria for a psychiatric diagnosis based on the DAWBA.

    Time frame: Day 1

  2. Emotional and behavioral difficulties

    SDQ results will be compared to Danish normative data.

    Time frame: Day 1

Secondary outcomes

  1. Feasibilty

    Feasibilty will be evaluated based on participation rate and acceptability of the screening procedure.

    Time frame: Day 1

  2. Unmet mental health needs

    Mental health service access and unment support needs are evaluated.

    Time frame: Day 1

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No — IPD will not be shared because of the sensitive nature of the data referring to children's psychological profile.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 26, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05709470
Lead sponsor
Rigshospitalet, Denmark
Collaborators
Danish Heart Foundation, The Danish DAWBA Center, Aalborg University Hospital, Aarhus University Hospital
Responsible party
Sara Hirani Lau-Jensen (Principal Investigater, Rigshospitalet, Denmark) — Principal investigator
First posted
Feb 2, 2023
Start date
Mar 17, 2023
Primary completion
Dec 31, 2025 (estimated)
Completion
Dec 31, 2025 (estimated)
Last update
Sep 26, 2025

Study contacts

Sara H Lau Jensen, M.D.
Contact
sara.hirani.lau-jensen@regionh.dk
004526192879
Julie L Hejl, M.D.
Contact
julhej@rm.dk
004529895828
Vibeke E Hjortdal, M.D, PhD, professor
study director · University of Copenhagen

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion